8-K
Current Report
Cartesian Therapeutics, Inc. Filed Acc 0001453687-17-000024
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading selectabiosciences8k_lmb-1.htm…